Alterity Therapeutics (ATHE) Other financing activities (2016 - 2017)
Alterity Therapeutics (ATHE) posted quarterly Other financing activities of $16.8 million for Q4 2017, down 20.84% year-over-year from $21.3 million in Q4 2016, and down 20.84% quarter-over-quarter from $21.3 million in Q4 2016.
Alterity Therapeutics (ATHE) Other financing activities (2016 - 2017) Analysis & Trends
Alterity Therapeutics' Other financing activities history runs 2 years deep, the most recent figure standing at $16.8 million for Q4 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.00 Bn | 132.14 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.31 Bn | 78.32 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.24 Bn | 60.06 Bn | 1.37 Bn |
| 4 | Moderna | 62.41 Bn | 57.27 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.25 Bn | 37.15 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.18 Bn | 27.88 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.93 Bn | 10.54 Bn | 668.28 Mn |
| 8 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.28 Bn | 26.44 Bn | - |
| 10 | Alterity Therapeutics | 50.86 Mn | 18.55 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2017 | 16.83 Mn |
| Dec 31, 2017 | 16.83 Mn |
| Dec 31, 2016 | 21.26 Mn |
| Dec 31, 2016 | 21.26 Mn |